Steven Cohen (Trades, Portfolio), founder of Point72 Asset Management, invested in a 2,255,000-share stake in Celator Pharmaceuticals Inc. (CPXX, Financial), an Ewing, New Jersey-based oncology-focused biopharmaceutical company, on March 14. Cohen paid $1.68 per share in a transaction that had a 0.03% impact on the guru’s portfolio.
Celator announced Tuesday that its CEO, Scott Jackson, will present a company overview at the 15th Annual Healthcare Conference in New York next week. A live webcast will be available on the investor section of Celator's website.
Cohen’s stake in Celator is 6.2% of the company’s outstanding shares and 0.03% of the guru’s total assets. First Eagle Investment (Trades, Portfolio) acquired a stake in Celator in the fourth quarter, purchasing 612,600 shares for an average price of $1.72 per share. The stake is 1.68% of Celator’s outstanding shares.
Celator has a P/B of 66.5. GuruFocus gives Celator a Financial Strength rating of 4/10 and a Profitability and Growth rating of 3/10.
Celator sold for $12.35 per share Tuesday afternoon.
To view the gurus' latest stock picks, visit the Real Time Stock Picks page. Not a premium member of GuruFocus? Try it free for seven days.
Also check out:
